|
2013 Other Outputs Methods of Modulating The Activity of the MC5 Receptor and Treatment of Conditions Related to This ReceptorMark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2013). Methods of Modulating The Activity of the MC5 Receptor and Treatment of Conditions Related to This Receptor. US8377925. |
|
2013 Other Outputs “3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor AntagonistsMark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2013). “3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8343958. |
|
2012 Journal Article Resolving biofilm infections: current therapy and drug discovery strategiesRanall, Max V., Butler, Mark S., Blaskovich, Mark A. and Cooper, Matthew A. (2012). Resolving biofilm infections: current therapy and drug discovery strategies. Current Drug Targets, 13 (11), 1375-1385. doi: 10.2174/138945012803530251 |
|
2012 Journal Article Lipoamino acids as major components of absorption promoters in drug deliveryZiora, Zyta M., Blaskovich, Mark A., Toth, Istvan and Cooper, Matthew A. (2012). Lipoamino acids as major components of absorption promoters in drug delivery. Current Topics in Medicinal Chemistry, 12 (14), 1562-1580. doi: 10.2174/156802612802652448 |
|
2012 Conference Publication New glycopeptidic antibiotics to combat multidrug resistant pathogensGong, Y., Muldoon, C. A., Premraj, R., Ziora, Z. M., Bradford, T. A., Cheng, M., Ramu, S., Huang, J. X., Kavanagh, A., Pelingon, R., Lee, J. C., Wong, K., Butler, M. S., Blaskovich, M. A. and Cooper, M. A. (2012). New glycopeptidic antibiotics to combat multidrug resistant pathogens. 32nd European Peptide Symposium, Athens, Greece, 2-7 September 2012. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.2449 |
|
2011 Other Outputs 3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor AntagonistsMark Arnold Thomas Blaskovich and Peter Joseph Cassidy (2011). 3-Aminoalkyl-1,4-Diazepan-2-One Melanocortin-5 Receptor Antagonists. US8008291. |
|
2010 Other Outputs Protein Tyrosine Phosphatase Inhibitors and Methods of Use ThereofMark Arnold Thomas Blaskovich, Ted Baughman, Thomas Little, Maher Qabar, Lauri Marie Schultz, Feng Hong, William Pratt, Gangadhar Nagula, Jennifer Lynn Gage and James Jeffry Howbert (2010). Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof. US7829737. |
|
2010 Other Outputs Modulating the activity of a receptor comprising melanocortin-3 receptor or melanocortin-4 receptor, comprises exposing the receptor to 1,4-diazepan-2-one compoundsBlaskovich, Mark and CASSIDY P J (2010). Modulating the activity of a receptor comprising melanocortin-3 receptor or melanocortin-4 receptor, comprises exposing the receptor to 1,4-diazepan-2-one compounds. WO2010096854-A1. |
|
2010 Other Outputs Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compoundBlaskovich, Mark and CASSIDY P J (2010). Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compound. WO2010096853-A1. |
|
2009 Other Outputs New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancersBLASKOVICH M A T and CASSIDY P J (2009). New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancers. WO2009105823-A1. |
|
2009 Other Outputs New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancersBLASKOVICH M A T and CASSIDY P J (2009). New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancers. WO2009105825-A1. |
|
2009 Other Outputs Use of 1,4-diazepan-2-one derivatives for down-regulating activity of melanocortin-5 receptor and treating, preventing or controlling a condition e.g. acne, and seborrheic dermatitisBLASKOVICH M A T and CASSIDY P J, (2009). Use of 1,4-diazepan-2-one derivatives for down-regulating activity of melanocortin-5 receptor and treating, preventing or controlling a condition e.g. acne, and seborrheic dermatitis. WO2009105824-A1. |
|
2009 Journal Article Drug discovery and protein tyrosine phosphatasesBlaskovich, M. A. T. (2009). Drug discovery and protein tyrosine phosphatases. Current Medicinal Chemistry, 16 (17), 2095-2176. doi: 10.2174/092986709788612693 |
|
2009 Other Outputs Protein tyrosine phosphatase inhibitors and methods of use thereofBlaskovich, Mark Arnold Thomas, Baughman, Ted, Little, Thomas, Patt, William, Qabar, Maher, Schultz, Lauri, Nagula, Gangadhar, Gage, Jennifer Lynn and Howbert, James Jeffry (2009). Protein tyrosine phosphatase inhibitors and methods of use thereof. US 07504389. |
|
2009 Other Outputs Protein Tyrosine Phosphatase Inhibitors and Methods of Use ThereofMark Arnold Thomas Blaskovich, Ted Baughman, Thomas Little, William Pratt, Maher Qabar, Laurie Marie Schultz, Gangadhar Nagula, Jennifer Lynn Gage and James Jeffry Howbert (2009). Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof. US7504389. |
|
2008 Journal Article A convenient reduction of α-amino acids to 1,2-amino alcohols with retention of optical purityHwang, Sun-Hee, Blaskovich, Mark A. and Kim, Hwa-Ok (2008). A convenient reduction of α-amino acids to 1,2-amino alcohols with retention of optical purity. Open Organic Chemistry Journal, 2 (1), 107-109. doi: 10.2174/1874095200802010107 |
|
2006 Other Outputs Protein tyrosine phosphatase inhibitors and methods of use thereofBlaskovich, Mark A., Little, Thomas, Qabar, Maher, Schultz, Lauri, Gage, Jennifer Lynn, Hong, Feng, Baughman, Ted, Patt, William, Howbert, James Jeffry and Nagula, Gangadhar (2006). Protein tyrosine phosphatase inhibitors and methods of use thereof. US2006142250(A1). |
|
2006 Other Outputs beta-sheet mimetics and composition and methods relating theretoBlaskovich, Mark A., Ogbu, Cyprian, O. and Kim, Hwa-Ok (2006). beta-sheet mimetics and composition and methods relating thereto. US7053214(B2). |
|
2006 Other Outputs Protein tyrosine pPhosphatase inhibitors and methods of use thereofBlaskovich, Mark A., Baughman, Ted, Little, Thomas, Patt, William, Qabar, Maher, Schultz, Lauri, Hong, Feng, Nagula, Gangadhar, Gage, Jennifer Lynn and Howbert, James Jeffry (2006). Protein tyrosine pPhosphatase inhibitors and methods of use thereof. WO/2006/055525. |
|
2005 Journal Article Design, synthesis, and evaluation of potent and selective benzoyleneurea-based inhibitors of protein geranylgeranyltransferase-1Carrico, D, Blaskovich, MA, Bucher, CJ, Sebti, SM and Hamilton, AD (2005). Design, synthesis, and evaluation of potent and selective benzoyleneurea-based inhibitors of protein geranylgeranyltransferase-1. Bioorganic & Medicinal Chemistry, 13 (3), 677-688. doi: 10.1016/j.bmc.2004.10.053 |
